Diffuse Large B-Cell Lymphoma: An Overview | MyLymphomaTeam
Limited-stage diffuse large B-cell lymphoma - ScienceDirect
PDF) Evaluation of BCL-6, CD10, CD138 and MUM-1 expression in diffuse large B-cell lymphoma patients: CD138 is a marker of poor prognosis | Ismail Matalka - Academia.edu
Diffuse large B-cell lymphoma - Wikipedia
C-MYC Aberrations as Prognostic Factors in Diffuse Large B-cell Lymphoma: A Meta-Analysis of Epidemiological Studies | PLOS ONE
Molecular profiling in diffuse large B‐cell lymphoma: why so many types of subtypes? - Morin - 2022 - British Journal of Haematology - Wiley Online Library
Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role? | Haematologica
Salvage Therapy for Relapsed/Refractory Diffuse Large B Cell Lymphoma – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
![PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7ef8b2d6bb8eef5420a757ef68eb53fcce0f81e5/5-Figure2-1.png "PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar")
PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar
Using biologic predictive factors to direct therapy of diffuse large B-cell lymphoma. - Abstract - Europe PMC
More accurate prognostic prediction in diffuse large B-cell lymphoma: beyond cell-of-origin - Annals of Oncology
miRNA-Based Therapies in B Cell Non-Hodgkin Lymphoma: Trends in Immunology
Non-Hodgkin lymphoma - Clinical
![A prognostic gene model of immune cell infiltration in diffuse large B-cell lymphoma [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2020/9658/1/fig-1-2x.jpg "A prognostic gene model of immune cell infiltration in diffuse large B-cell lymphoma [PeerJ]")
A prognostic gene model of immune cell infiltration in diffuse large B-cell lymphoma [PeerJ]
![PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7ef8b2d6bb8eef5420a757ef68eb53fcce0f81e5/3-Figure1-1.png "PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar")
PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar
![PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7ef8b2d6bb8eef5420a757ef68eb53fcce0f81e5/6-Figure3-1.png "PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar")
PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar
Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces - eBioMedicine
Biological Prognostic Markers in Diffuse Large B-Cell Lymphoma
The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management - Marchi - 2020 - CA: A Cancer Journal for Clinicians - Wiley Online Library
CHN1 is prognostic marker for diffuse large B-cell lymphoma | PGPM
Diffuse Large B-Cell Lymphoma | NEJM
Frontiers | Metabolic Reprogramming of Non-Hodgkin's B-Cell Lymphomas and Potential Therapeutic Strategies
Hemato | Free Full-Text | Diffuse Large B-Cell Lymphoma: Recognition of Markers for Targeted Therapy
Diffuse Large B-Cell Lymphoma | NEJM
Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era. | Semantic Scholar
JCM | Free Full-Text | Phenotypic Characterization of Diffuse Large B-Cell Lymphoma Cells and Prognostic Impact
Appropriate Management of Molecular Subtypes of Diffuse Large B-Cell Lymphoma
